1-Methylpyrrolidine

CAS No. 120-94-5

1-Methylpyrrolidine( —— )

Catalog No. M21557 CAS No. 120-94-5

1-Methylpyrrolidine is extensively used in the synthesis of pyrrolidine based ionic liquids.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-Methylpyrrolidine
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Methylpyrrolidine is extensively used in the synthesis of pyrrolidine based ionic liquids.
  • Description
    1-Methylpyrrolidine is extensively used in the synthesis of pyrrolidine based ionic liquids.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    120-94-5
  • Formula Weight
    85.15
  • Molecular Formula
    C5H11N
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (1174.40 mM)
  • SMILES
    CN1CCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-Methylsuccinic aci...

    Methylsuccinic acid is a normal metabolite found in human fluids. Increased urinary levels of Methylsuccinic acid (together with ethylmalonic acid) are the main biochemical measurable features in ethylmalonic encephalopathy a rare metabolic disorder with an autosomal recessive mode of inheritance that is clinically characterized by neuromotor delay hyperlactic acidemia recurrent petechiae orthostatic acrocyanosis and chronic diarrhea.

  • KHK-IN-1

    KHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.

  • TFEB activator 1

    TFEB activator 1 is an activator?of transcription factor EB (TFEB) ?with promise for the prevention or treatment of Alzheimer's disease.